-
-
-
-
-
-
-
Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance
-
-
-
-
-
-
-
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
-
-
-
-
-
-
-
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration
-
-
-
-
-
-
-
Myriad Genetics Expands Partnership with Intermountain Precision Genomics to Add Liquid Biopsy Therapy Selection Offering to Portfolio of Precise™ Oncology Solutions
-
-
-
-
-
-
-
Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Promotes Nicole Lambert to COO
-
-
-
-
-
-
-
Bragar Eagel & Squire is Investigating Certain Officers and Directors of CarLotz, Myriad Genetics, and AMC Entertainment on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Fir
-
924,088 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All